Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2017	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	2,601,378		$	133,537		$	—		$	2,467,841
Less: Provision for uncollectible accounts	(112,983		)	(3,725		)	—			(109,258		)
Net patient service operating revenues	2,488,395			129,812			—			2,358,583
Capitated revenues	918,036			384,262			—			533,774
Other revenues	290,852			9,851			—			281,001
Total net operating revenues	3,697,283			523,925			—			3,173,358
Operating expenses	2,809,047			500,390			(166		)	2,308,823
Operating income	888,236			23,535			166			864,535
Debt expense, including refinancing charges	(104,429		)	(1,450		)	—			(102,979		)
Other income	4,243			35			—			4,208
Income tax expense	287,765			18,594			66			269,105
Net income (loss)	500,285			3,526			100			496,659
Less: Net income attributable to noncontrolling interests	(52,588		)	—			—			(52,588		)
Net income (loss) attributable to DaVita Inc.	$	447,697		$	3,526		$	100		$	444,071


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2017	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income (loss)	$	500,285		$	3,526	$	100	$	496,659
Other comprehensive loss	12,755			—		—		12,755
Total comprehensive income (loss)	513,040			3,526		100		509,414
Less: comprehensive income attributable to the noncontrolling interests	(52,586		)	—		—		(52,586		)
Comprehensive income (loss) attributable to DaVita Inc.	$	460,454		$	3,526	$	100	$	456,828


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of March 31, 2017	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	1,472,232	$	99,086	$	—	$	1,373,146
Accounts receivable, net	1,900,561		202,006		—		1,698,555
Other current assets	1,231,107		14,819		—		1,216,288
Total current assets	4,603,900		315,911		—		4,287,989
Property and equipment, net	3,171,199		1,268		—		3,169,931
Amortizable intangibles, net	1,487,029		4,576		—		1,482,453
Other long-term assets	673,666		81,419		2,880		589,367
Goodwill	9,452,470		16,796		—		9,435,674
Total assets	$	19,388,264	$	419,970	$	2,880	$	18,965,414
Current liabilities	$	2,813,577	$	204,998	$	—	$	2,608,579
Payables to parent	—		61,723		2,880		(64,603		)
Long-term debt and other long-term liabilities	10,254,248		45,226		—		10,209,022
Noncontrolling interests subject to put provisions	979,848		—		—		979,848
Total DaVita Inc. shareholders’ equity	5,139,929		108,023		—		5,031,906
Noncontrolling interests not subject to put provisions	200,662		—		—		200,662
Shareholders’ equity	5,340,591		108,023		—		5,232,568
Total liabilities and shareholder’s equity	$	19,388,264	$	419,970	$	2,880	$	18,965,414


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2017	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	500,285		$	3,526		$	100		$	496,659
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	364,889			(14,847		)	(100		)	379,836
Net cash provided by (used in) operating activities	865,174			(11,321		)	—			876,495
Cash flows from investing activities:
Additions of property and equipment	(214,535		)	(10		)	—			(214,525		)
Acquisitions and divestitures, net	(77,236		)	—			—			(77,236		)
Proceeds from discontinued operations	46,612			—			—			46,612
Investments and other items	(4,853		)	(946		)	—			(3,907		)
Net cash used in investing activities	(250,012		)	(956		)	—			(249,056		)
Cash flows from financing activities:
Long-term debt	(36,141		)	—			—			(36,141		)
Intercompany	—			6,672			—			(6,672		)
Other items	(22,796		)	—			—			(22,796		)
Net cash (used in) provided by financing activities	(58,937		)	6,672			—			(65,609		)
Effect of exchange rate changes on cash	2,820			—			—			2,820
Net increase (decrease) in cash	559,045			(5,605		)	—			564,650
Cash and cash equivalents at beginning of period	913,187			104,691			—			808,496
Cash and cash equivalents at end of period	$	1,472,232		$	99,086		$	—		$	1,373,146